Related Experiment Video
Updated: Jun 23, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Novel strategies for improved cancer vaccines
Xiaochuan Chen1, Chien-Hsing Chang, David M Goldenberg
1Garden State Cancer Center, CMMI, Belleville, NJ 07109, USA. mchen@gscancer.org
Abstract:
Therapeutic vaccination against cancer is an important modality complementing current standard therapies and may lead to long-term control of cancer. Numerous strategies are in development in an attempt to achieve better effectiveness but, except for the recent advent of vaccines against human papillomavirus, the long effort to produce a cancer vaccine has not succeeded. Nevertheless, a number of novel approaches can be pursued that, in our view, include optimized antigen design, in vivo-targeted dendritic cell vaccination and cancer vaccines used in combination with chemotherapy, monoclonal antibodies, adoptive T-cell transfer or stem cell transplantation. This article summarizes the rationale and development of these approaches for improved cancer vaccines.
Insights
Developing effective cancer vaccines remains a challenge, but novel strategies like optimized antigen design and combination therapies show promise for long-term cancer control.
Area of Science:
- Oncology
- Immunology
- Vaccinology
Background:
- Therapeutic cancer vaccines are a crucial addition to standard cancer treatments, aiming for long-term disease control.
- Despite decades of research, successful therapeutic cancer vaccines have been limited, with notable exceptions like human papillomavirus vaccines.
Purpose of the Study:
- To review and summarize novel approaches for enhancing the effectiveness of therapeutic cancer vaccines.
- To discuss the rationale and developmental progress of these innovative strategies.
Main Methods:
- Review of current research and development in therapeutic cancer vaccine strategies.
- Focus on novel approaches including antigen optimization, dendritic cell targeting, and combination therapies.
Main Results:
- Several promising strategies are under investigation to improve cancer vaccine efficacy.
- Optimized antigen design, in vivo-targeted dendritic cell vaccination, and combination treatments are key areas of development.
Conclusions:
- Novel approaches hold significant potential for advancing therapeutic cancer vaccines.
- Combining cancer vaccines with chemotherapy, monoclonal antibodies, adoptive T-cell transfer, or stem cell transplantation may improve outcomes.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...

